PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
RevitaLash® Cosmetics Introduces RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, a Revolutionary Lash Serum Made without Prostaglandin Analogues
2026-09-29T    Cosmetics & Personal Care   Household/Consumer/Cosmetics   Medical/Pharmaceuticals   Retail 
Yuyu Teijin Medicare Uses Drones to Deliver Medical Supplies to Patients on Korea's Remote Islands
2026-09-29T    Health Care/Hospital   Infectious Disease Control   Medical Equipment   Medical/Pharmaceuticals 
Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses
2026-09-29T    Health Care/Hospital   Higher Education   Medical Equipment   Medical/Pharmaceuticals 
Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses
2026-09-29T    Health Care/Hospital   Higher Education   Medical Equipment   Medical/Pharmaceuticals 
CAS announces collaboration with Novartis to advance AI-ready reaction informatics
2026-09-29T    Biotechnology   Computer/Electronics   Medical/Pharmaceuticals 
Providence Therapeutics Announces Formation of Oncology Clinical Advisory Board
2026-09-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
iRegene Therapeutics's NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa
2026-09-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
2026-09-29T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Vitaceuticals Founders Win National Manufacturing Award for Australian-Made Health Range
2026-09-29T    Health Care/Hospital   Medical/Pharmaceuticals 
Ascletis Announces Positive Results from 28-Day Proof-of-Concept Clinical Study in U.S. for ASC50, a First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor for the Treatment of Plaque Psoriasis
2026-09-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.